Page last updated: 2024-08-22

platinum and carfilzomib

platinum has been researched along with carfilzomib in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Arnold, SM; Baggstrom, MQ; Chansky, K; Crowley, JJ; Hamm, J; Leggas, M; Rosales, J; Sanborn, RE; Thompson, MA; Villano, JL; Waqar, SN; Willis, M	1

Trials

1 trial(s) available for platinum and carfilzomib

Article	Year
Phase II Trial of Carfilzomib Plus Irinotecan in Patients With Small-cell Lung Cancer Who Have Progressed on Prior Platinum-based Chemotherapy. Clinical lung cancer, 2020, Volume: 21, Issue:4 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Female; Follow-Up Studies; Humans; Irinotecan; Lung Neoplasms; Male; Middle Aged; Oligopeptides; Platinum; Prognosis; Small Cell Lung Carcinoma; Survival Rate	2020

Article

Year

Phase II Trial of Carfilzomib Plus Irinotecan in Patients With Small-cell Lung Cancer Who Have Progressed on Prior Platinum-based Chemotherapy.

Clinical lung cancer, 2020, Volume: 21, Issue:4

Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Female; Follow-Up Studies; Humans; Irinotecan; Lung Neoplasms; Male; Middle Aged; Oligopeptides; Platinum; Prognosis; Small Cell Lung Carcinoma; Survival Rate

2020